Wealth Enhancement Advisory Services, LLC Blueprint Medicines Corp Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 3,353 shares of BPMC stock, worth $341,469. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,353Holding current value
$341,469% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
394Shares Held
61.2MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$690 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$677 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$578 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$255 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$198 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.08B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...